In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Charles River Laboratories International Inc (NYSE: CRL) closed the day trading at $163.50 down -1.39% from the previous closing price of $165.80. In other words, the price has decreased by -$1.39 from its previous closing price. On the day, 1.15 million shares were traded. CRL stock price reached its highest trading level at $167.5 during the session, while it also had its lowest trading level at $163.08.
Ratios:
For a better understanding of CRL, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 39.72 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.92. For the most recent quarter (mrq), Quick Ratio is recorded 1.14 and its Current Ratio is at 1.48. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on January 17, 2025, Downgraded its rating to Neutral and sets its target price to $185 from $250 previously.
On November 18, 2024, CLSA Downgraded its rating to Underperform which previously was Hold but kept the price unchanged to $164.
CLSA Upgraded its Underperform to Hold on November 07, 2024, while the target price for the stock was maintained at $205.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 07 ’24 when WALLMAN RICHARD F sold 6,621 shares for $216.12 per share. The transaction valued at 1,430,918 led to the insider holds 12,386 shares of the business.
WALLMAN RICHARD F sold 1,000 shares of CRL for $216,500 on Nov 07 ’24. The Director now owns 0 shares after completing the transaction at $216.50 per share. On Nov 07 ’24, another insider, WALLMAN RICHARD F, who serves as the Director of the company, bought 12,161 shares for $216.01 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRL now has a Market Capitalization of 8360768512 and an Enterprise Value of 10958727168. As of this moment, Charles’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.19, and their Forward P/E ratio for the next fiscal year is 16.22. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 7.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.06 while its Price-to-Book (P/B) ratio in mrq is 2.21. Its current Enterprise Value per Revenue stands at 2.699 whereas that against EBITDA is 11.55.
Stock Price History:
The Beta on a monthly basis for CRL is 1.39, which has changed by -0.24242425 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, CRL has reached a high of $275.00, while it has fallen to a 52-week low of $160.85. The 50-Day Moving Average of the stock is -14.86%, while the 200-Day Moving Average is calculated to be -20.95%.
Shares Statistics:
Over the past 3-months, CRL traded about 738.34K shares per day on average, while over the past 10 days, CRL traded about 1077700 shares per day. A total of 51.13M shares are outstanding, with a floating share count of 50.59M. Insiders hold about 1.08% of the company’s shares, while institutions hold 102.70% stake in the company. Shares short for CRL as of 1735603200 were 2257761 with a Short Ratio of 3.06, compared to 1732838400 on 2179281. Therefore, it implies a Short% of Shares Outstanding of 2257761 and a Short% of Float of 5.7299999999999995.
